Back to 15Rock Review
The Dwell Audit: Why Your Bottleneck Is the Waiting, Not the Working
Whitepaper · Portfolio OperationsSeptember 28, 2026Updated November 3, 202612 min read

The Dwell Audit: Why Your Bottleneck Is the Waiting, Not the Working

A high-tech assembly line spent 99.8% of its lead time waiting. A reporting process took 8 weeks per report. The bottleneck is rarely the machines — it is the dwell between…

Ray Hertanto

15Rock Review

Walk onto almost any factory floor on a Tuesday morning and every machine looks intensely busy. Follow a single part with a stopwatch and you see the truth: the product sits idle 91.3% of the time. In our Process Cycle Efficiency (PCE) Dwell Audit of a tactical drone line, active work totaled 48.3 minutes across 556.0 minutes of lead time (8.7% PCE). Parallelizing the curing bottleneck modeled a ~200% throughput gain with zero new machines.

The finding: across manufacturing, logistics, retail, and finance, 86% to 99.8% of cycle time is queue dwell

Exhibit 1: Process Cycle Efficiency (PCE) audit across manufacturing and enterprise workflows showing 86.2% to 99.8% of total lead time consumed by inter-stage queue wait.
Exhibit 1: Process Cycle Efficiency (PCE) audit across manufacturing and enterprise workflows showing 86.2% to 99.8% of total lead time consumed by inter-stage queue wait.

When output falls behind customer orders, operating executives instinctively audit machine spindle speed and operator utilization (often 85%+ with heavy overtime). But Exhibit 1 reveals that speeding up active touch time touches less than 9% of total elapsed lead time while products sit for hours in unmeasured batch and curing queues (0.18% PCE at the bottleneck). Therefore, buying faster machinery before eliminating inter-station dwell simply moves work-in-process into a bigger pile.

When we flip the lens from the machine’s activity to the product’s chronological journey (Process Cycle Efficiency, or PCE), a completely different reality emerges across seven distinct industries in our research corpus:

Industry & Operational WorkflowTotal Elapsed Cycle vs. Active WorkProcess Cycle Efficiency (PCE %)Primary Structural Dwell BottleneckQuantified Throughput / Financial UnlockEpistemic Provenance
1. Sub-25kg Tactical UAV Final Assembly556.0 min total serial lead time vs. 48.3 min total active work (1.0 min active dispense at adhesive bottleneck stage)8.7% line PCE (0.18% at adhesive-cure stage; 507.7 min line queue)Single serial line blocked by batch adhesive curing and sequential avionics sign-off~200% throughput gain (16.4-min cell cycle time vs. 17.1-min demand takt; C$50,400 blended ASP vs. C$19,800 at-scale unit BoM = 60.7% GM)[Calculated / Modeled] — 15Rock UAV Value-Stream Map
2. Institutional ESG & Carbon Underwriting8 weeks (320 hrs) elapsed per asset report vs. 11.5 hrs actual modeling3.6% PCE (96.4% sequential handoff dwell)Serial review queues creating an estimated ~15-year portfolio backlog80%+ cycle compression (8 weeks → 3–5 days) via parallel multi-agent synthesis[Observed] — 15Rock Pension & Credit Workflow Scan
3. US Marine Container Terminal Drayage4.2-day container yard dwell + 110-min truck gate turn time12.5% PCE (87.5% yard re-handling & gate queue)Unscheduled drayage arrivals and uncoordinated ship-to-shore crane telemetry$44.0M+ annual terminal value via AI gate slotting and crane digital twins[Modeled] — 15Rock 4-Part Port Terminal Study
4. Biologics Drug-Substance Campaign Release45-day batch manufacture & QA release vs. 6.2-day active bioreactor/purification time13.8% PCE (86.2% sequential QC & paper batch hold)Serial quality-control assay queues and un-parallelized suite changeover cleaning2.0x effective plant capacity (+100% output) with zero new bioreactor CapEx[Calculated] — 15Rock Biomanufacturing Audit

Notice the two ways elite operators monetize a dwell audit:

  • In production, logistics, and merchandising (Cases 1–6): Dwell is pure waste—compressing it triples output (+200% UAV throughput), doubles biologics capacity with $0 CapEx, or saves $42M–$44M in logistics drag.
  • In customer retail environments (Case 7): When physical physics creates an unavoidable 18-minute EV fast-charging dwell, empirical Norwegian forecourt telemetry proves that re-architecting the convenience store around barista coffee, fresh food, and lounge seating converts captive customer waiting into a $450 million high-margin merchandise pool, offsetting 100% of motor-fuel volume decline.

The framework: Little’s Law, Cycle-Time vs. Takt-Time Alignment, and the 3-Cell Parallelization Proof

Exhibit 2: Decomposing a 556.0-minute tactical UAV serial lead time (48.3 min total active assembly work = 8.7% line PCE; 1.0 min active dispense at the 0.18% PCE adhesive bottleneck stage) and the 3-cell parallelization redesign.
Exhibit 2: Decomposing a 556.0-minute tactical UAV serial lead time (48.3 min total active assembly work = 8.7% line PCE; 1.0 min active dispense at the 0.18% PCE adhesive bottleneck stage) and the 3-cell parallelization redesign.

A rigorous Dwell Audit replaces subjective floor walks with three deterministic industrial-engineering equations:

1. Process Cycle Efficiency (PCE) & Wait-to-Work Ratio:

PCE = ( Σ{i=1..n} Touch_Time_i ) / ( Σ{i=1..n} Touch_Time_i + Σ{j=1..n} Queue_Dwell_j )

2. Little’s Law & Kingman’s Queue Explosion Formula:

Lead_Time (W) = WIP / Throughput (λ) and Queue_Dwell ≈ [ u / (1 − u) ] × [ (c_a^2 + c_s^2) / 2 ] × t_service

(Why 95% utilization destroys lead time: as station utilization u → 0.95, the queue multiplier u/(1−u) explodes to 19x service time whenever arrival or process variance c^2 > 0.)

3. Worked 3-Cell Parallelization Proof (Sub-25kg Tactical UAV Line):

- Serial Baseline (8.7% Line PCE / 0.18% Bottleneck Stage PCE): Across the full serial line, cumulative active touch work totaled 48.3 minutes (15.8 + 16.1 + 16.4 min of mechanical, avionics, and optical integration) against 507.7 minutes of serial starvation, blocking, and batch epoxy curing = 556.0 minutes elapsed lead time (8.7% line-wide PCE). At the single worst bottleneck gate (structural adhesive dispensing and batch curing), active touch work was just 1.0 minute against 555.0 minutes of cure and queue hold (0.18% stage PCE).

- Parallel Cell Redesign: Decoupling the line into three independent parallel sub-assembly cells — Cell A (Airframe & Propulsion) at 15.8 min, Cell B (Avionics, EO/IR & Flight Stack) at 16.1 min with offline curing, and Cell C (Final Integration & Optical Calibration) at 16.4 min — partitioned the 48.3 minutes of active work across three parallel cells, locked in a 16.4-minute balanced cell cycle time (paced safely below the 17.1-minute customer-demand takt time for 28 units/shift), and modeled a ~200% shift throughput increase (3.0x output) at a C$50,400 blended ASP against a C$19,800 at-scale (N = 500) modeled production unit BoM (60.7% gross margin; down from C$28,400 prototype BoM).

To diagnose why conventional factory dashboards miss a 555:1 wait-to-work ratio, compare what standard ERP/MES metrics report against what a Dwell Audit measures:

Conventional Factory / Operations MetricWhy It Looks “Green” on Executive DashboardsWhat the Metric Actively Hides (The Dwell Blind Spot)Dwell Audit Counter-Metric
Machine / Resource Utilization (%)Rewards keeping every CNC mill, analyzer, or staffer at 90%–95% busynessKingman’s equation: running stations above 85% without buffer decoupling causes exponential WIP queue explosions (19x wait multiplier)Process Cycle Efficiency (PCE %) & Station Starvation/Blocking logs
Per-Station Standard Cycle TimeTracks whether Station 4 completed its weld or assay in 12.0 minutesIgnores the 48 hours the pallet sat on a concrete floor waiting to enter Station 4End-to-End Traveller Elapsed Time (Timestamped dock-to-dock)
Gross Batch Output per WeekEncourages large batch runs to minimize setup changeoversLarge batching inflates downstream DIO and pushes apparel/seasonal SKUs past demand windows (22% negative-margin SKUs)Single-Piece Takt Time & Contribution Margin net of markdowns

The trap: buying faster machines to speed up a 1% touch step

When an assembly line takes 10 hours to produce a unit, and active machining or assembly represents only 6 minutes (1%) of those 10 hours, buying a $5 million robotic cell that cuts active touch time in half—from 6 minutes to 3 minutes—reduces total lead time from 600 minutes to 597 minutes (a 0.5% improvement).

Meanwhile, reorganizing the existing stations from a single serial queue into three parallel sub-assembly cells with offline curing and pre-kitted harnesses cuts the 594 minutes of waiting by 70%+—tripling capacity for the price of floor tape, kitting carts, and standard work instructions.

The tell: If a capital-expenditure request proposes buying new machines to solve a delivery backlog, but cannot state the line’s current Process Cycle Efficiency (PCE) or show a timestamped decomposition of active touch hours vs. inter-stage queue hours, the team is automating the 1% while ignoring the 99%.

The decision agenda: what to do differently

Exhibit 3: Parallel cell cycle-time balancing across a tactical UAV assembly line—partitioning 48.3 minutes of active work into 3 parallel cells (15.8m, 16.1m, 16.4m) to achieve a 16.4-minute cell cycle time below the 17.1-minute customer-demand takt time (~200% throughput gain).
Exhibit 3: Parallel cell cycle-time balancing across a tactical UAV assembly line—partitioning 48.3 minutes of active work into 3 parallel cells (15.8m, 16.1m, 16.4m) to achieve a 16.4-minute cell cycle time below the 17.1-minute customer-demand takt time (~200% throughput gain).
  1. Mandate a Dwell Audit before approving any capacity CapEx. Require every plant, laboratory, or service operation requesting expansion capital to instrument 20 unit travellers from intake to shipment and report exact PCE %.
  2. Parallelize serial gates and move curing/QC off the critical path. As demonstrated in our tactical UAV (8.7% line PCE / 0.18% bottleneck stage PCE → 16.4-min cell cycle time vs. 17.1-min customer takt, +200% throughput) and biologics (2.0x capacity) diagnostics, decouple sub-assemblies into parallel cells so a single slow cure or assay never halts the main line.
  3. Compress merchandising and logistics calendars to protect margin. Cut apparel design-to-rack cycles from 28 weeks toward the 14-week peer median to eliminate the end-of-season markdown cliff (22% of SKUs in negative margin), and synchronize clinical lab courier pickups with analyzer batch windows ($42.0M / -16% savings).
  4. Monetize unavoidable customer dwell. Where physical laws mandate a 15-to-20-minute customer wait (such as EV ultra-fast charging forecourts), re-engineer the physical retail box around high-margin hospitality and fresh food ($450M margin pool).

What could break this read

  • Coordination and floor-space limits on cell splitting: Splitting a serial line into three parallel cells yields a massive step-change (~200% throughput), but splitting into ten micro-cells eventually introduces duplicate test-rig capital and material-handler congestion that outweigh queue reductions.
  • Regulatory batch-quarantine mandates: In sterile pharmaceuticals and energetic munitions, statutory compendial sterility tests (14-day incubation) or lot ballistic acceptance gates impose hard minimum hold times that cannot be parallelized away without regulator-approved rapid microbiological methods (RMM).

The checklist

  • Do we know our exact Process Cycle Efficiency (PCE = Active Touch Time ÷ Total Elapsed Lead Time) across our core production, R&D, and quoting workflows?
  • Where is the unit, specimen, container, or report physically sitting during the 85% to 99% of elapsed time when nobody is working on it?
  • Can we decouple a single serial line into parallel sub-assembly cells (16.4-min balanced cell cycle time below the 17.1-min demand takt) or run quality/compliance checks concurrently before buying new equipment?
  • In seasonal retail or supply chains, how many points of gross margin are we losing to markdowns (22% negative-margin SKUs) caused by a 28-week vs. 14-week cycle lag?
  • Where customer dwell is physically unavoidable (18-minute EV charging), have we designed the retail footprint to monetize the wait?

The rule: measure the product’s chronological journey, not the machine’s busyness—attack the 91% of time spent waiting before you spend a dollar speeding up the 9% spent working. Approving a $5.0M robotics upgrade on an un-decomposed 0.5% PCE line saves just 3 minutes out of 600 while stranding millions in unproductive capex.

Sources

  1. Little, J. D. C. (1961) & Kingman, J. F. C. (1961) — Queueing Theory & Factory Physics Foundations: Mathematical proofs governing WIP = λ × W and non-linear queue waiting-time expansion under high station utilization and variance.
  2. 15Rock Sub-25kg Tactical UAV Value-Stream & Industrial Engineering Study (2026): 48.3 min total active assembly work across 556.0 min serial lead time (8.7% line PCE; 0.18% stage PCE at the 1.0-min adhesive-cure bottleneck gate); 3-cell parallelized architecture partitioning the 48.3 min of work into a 16.4-minute balanced cell cycle time (below the 17.1-minute customer-demand takt time) and modeling a ~200% throughput uplift at a C$50,400 blended ASP and C$19,800 at-scale production unit BoM (60.7% gross margin).
  3. 15Rock Cross-Industry Dwell & Throughput Diagnostic Library (2026): Apparel design-to-rack teardown (28-week vs. 14-week peer cycle; 22% of “Tops” SKUs in negative margin); clinical laboratory courier optimization (-16% logistics cost = $42.0M savings); US marine container terminal AI gate/crane twin study ($44.0M+ dwell savings); biologics batch scheduling (2.0x effective capacity with $0 CapEx); EV forecourt charging dwell telemetry (18-min dwell = $450M retail margin pool); institutional ESG reporting (8 weeks/report compressed to 3–5 days).

Figures reflect observed value-stream time studies, calculated efficiency ratios, and modeled throughput bridges from 15Rock client engagements. Client and facility names are strictly withheld.

Where this fits at 15Rock
Related reads

Stay in the thread.

For investors and portfolio teams

Start with one company diagnostic.

Where the value or the risk sits in the company you choose, against its peers, with the evidence beside each finding.